Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5

Topline Pfizer and BioNTech on Monday said they will ask the Food and Drug Administration to authorize a three-shot regimen of their Covid-19 vaccine for children under five citing promising clinical ...

Immix Biopharma’s stock rockets after pediatric cancer treatment granted RPD by the FDA

Shares of Immix Biopharma Inc. IMMX, +9.20% rocketed 66.0% in premarket trading Monday, after the biopharmaceutical company said its IMX-110 was granted Rare Pediatric Disease (RPD) designation by the...